Cargando…
Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common female endocrine disease. Cangfu Daotan Decoction (CDD) can effectively relieve the clinical symptoms of PCOS patients. METHODS: To explore the active ingredients and related pathways of CDD for treating PCOS, a network pharmacology-bas...
Autores principales: | Xu, Wenting, Tang, Mengyu, Wang, Jiahui, Wang, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057008/ https://www.ncbi.nlm.nih.gov/pubmed/32148541 http://dx.doi.org/10.1155/2020/4086864 |
Ejemplares similares
-
Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Park, Hye-Rin, et al.
Publicado: (2019) -
Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Linling, et al.
Publicado: (2022) -
Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment
por: Liu, Shuowen, et al.
Publicado: (2022) -
Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis
por: Li, Yuan, et al.
Publicado: (2023) -
Mechanism of Xiaoying Daotan decoction in treating Hashimoto’s thyroiditis based on the Notch/Treg/Th17 pathway
por: Zhou, Yingjia, et al.
Publicado: (2021)